Ours and previously published studies (23, 31, 41, 60) thus provide reliable evidence for the relevance of MCAM dependent CNS invasion of T-cells, indicating MCAM blockade to be a suitable treatment approach for MS patients. The gene discussed is MCAM; the disease is myeloid sarcoma.